Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase

Area of Science:

• Immunology
• Molecular Biology
• Signal Transduction

Background:

• Interferons and cytokines regulate gene expression through JAK-STAT pathways.
• The interferon-alpha (IFN-α) pathway, involving receptors IFNaR1/IFNaR2 and JAK kinases (TYK2/JAK1), serves as a model system.
• Understanding the molecular interactions within this pathway is key for therapeutic development.

Purpose of the Study:

• To define the specific molecular interface on TYK2 responsible for binding to the IFNaR1 receptor.
• To elucidate the functional consequences of this interaction in the context of IFN-α signaling.

Main Methods:

• In vitro binding assays using glutathione S-transferase-TYK2 fusion proteins.
• Analysis of binding affinity using varying lengths of TYK2 fragments.
• Reporter gene assays to assess transcriptional inhibition.
• Western blotting to evaluate tyrosine phosphorylation of signaling proteins.

Main Results:

• The amino-terminal half of TYK2 (approx. 600 amino acids, JH3-7 domains) constitutes the maximal binding domain for IFNaR1.
• Specific domains, JH6 and JH3, were identified as major interaction sites with IFNaR1.
• A TYK2 fragment (amino acids 1-601) inhibited IFN-α-dependent gene transcription and phosphorylation of TYK2, STAT1, and STAT2.

Conclusions:

• The N-terminal region of TYK2, particularly JH3 and JH6 domains, is critical for IFNaR1 binding.
• This interaction is essential for mediating IFN-α-induced signaling.
• Targeting this interface may offer a strategy for modulating IFN-α responses.